TABLE 1.
Na+ kinetics |
TCA kinetics |
|||
---|---|---|---|---|
Jmax | KNa | Jmax | KTCA | |
pmol/min/mg protein | mm | pmol/min/mg protein | μm | |
C270A | 380.3 ± 16.8 | 8.9 ± 1.6 | 892.8 ± 57.7 | 9.7 ± 2.4 |
N27Cab | 934 ± 8.2 | 34.0 ± 8.3e | 312.5 ± 28.7 | 21.5 ± 6.2 |
N28C | 347.7 ± 25.1 | 5.5 ± 2.0 | 1469.0 ± 55.6 | 17.7 ± 2.2 |
L30Cabc | 198.1 ± 8.2 | 19.5 ± 2.6e | 1047.0 ± 183.5 | 59.8 ± 25.0e |
L34Cacd | 178.4 ± 6.9 | 7.5 ± 1.2 | 592.7 ± 23.3 | 11.6 ± 1.7 |
S35Cac | 270.3 ± 9.4 | 11.3 ± 1.5 | 389.5 ± 35.6 | 5.7 ± 2.6 |
T36Cacd | 336.5 ± 16.7 | 9.9 ± 1.9 | 801.8 ± 37.1 | 8.6 ± 1.6 |
L38Cbcd | 716.6 ± 54.7 | 24.1 ± 5.6e | 1507.0 ± 32.2e | 10.6 ± 0.9 |
T39Cbc | 406.9 ± 17.5 | 16.4 ± 2.4e | 553.5 ± 70.0 | 6.3 ± 3.6 |
M46Cab | 164.2 ± 8.4 | 1.3 ± 0.8e | 239.2 ± 25.2 | 8.4 ± 3.3 |
F47C | 297.6 ± 13.0 | 12.8 ± 2.0 | 453.8 ± 64.6 | 6.5 ± 4.0 |
a Decreased uptake due to mutation.
b Sodium sensitive.
c MTSET inhibition.
d Substrate protection.
e Parameters significantly different from the C270A control are indicated, *p ≤ 0.05.